Halitosis is a clinical condition characterized by unpleasant odor present in the mouth due to various periodontal and chronic diseases. It has become a social problem affecting large number of people across the world. The most common cause of halitosis is lack of oral hygiene and lack of awareness about diagnosis of this disease.
Halitosis treatment market is expected to show a massive growth due to availability of a wide range of dental health care products, increasing geriatric population and rising prevalence of periodontal diseases.

The global Halitosis Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Halitosis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Halitosis Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Halitosis Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Halitosis Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Colgate-Palmolive Company
Dr. Harold Katz
Rowpar Pharmaceuticals
Abbott
Listerine
AstraZeneca
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type

By Type

Pathologic Halitosis
Others
By Indication
Respiratory
Liver
Kidney
Gastrointestinal
Systemic
Others
By Drug Treatment
Antacids
Antiseptics
Ranitidine
Others

Segment by Application
Hospitals
Clinics